Journal of Clinical Oncology 2018 36:13, 1284-1290
- This study compared the effect of adding a clinician-delivered bedside pain assessment and management tool (Edinburgh Pain Assessment and management Tool [EPAT]) to usual care (UC) versus UC alone on pain outcomes in inpatients in cancer centres (n=1,795). Results demonstrate that the EPAT tool demonstrated a significant improvement in worst pain without increasing opioid adverse effects.
- Study: Two-arm, parallel group, cluster randomised (1:1) trial in 19 cancer centres in the United Kingdom involving 1,795 patients. Primary outcome - change in the percentage of study participants in each centre with a clinically significant (≥ 2 point) improvement in worst pain (using the Brief Pain Inventory Short Form) from admission to 3 to 5 days after admission. Secondary outcomes included quality of analgesic prescribing and opioid-related adverse effects.
